Cronos Group (CRON) Reports Q2 EPS of $0.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cronos Group Reports 2021 Second Quarter Results
August 6, 2021 7:30 AM EDTAmended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids
Announced strategic investment in PharmaCann, a leading U.S. cannabis company
Spinach launched new products in the edible, concentrate, and flower categories in Canada
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)Â (TSX: CRON) (Cronos Group or the Company), today announces its 2021 Second Quarter business results.
This quarter, Cronos Group continued to bring high-quality and insight-driven... More
